Nevro Corp. (NVRO) Social Stream
NEVRO CORP (NVRO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEVRO CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $160 | $105 | $127.909 | $19.36 | 560.69% |
| 2021-11-19 | 12 | $160 | $90 | $124.1 | $19.36 | 541.01% |
| 2021-12-06 | 12 | $160 | $90 | $124.1 | $19.36 | 541.01% |
| 2021-12-21 | 12 | $160 | $90 | $123.1 | $19.36 | 535.85% |
| 2022-01-03 | 12 | $160 | $90 | $120.6 | $19.36 | 522.93% |
| 2022-01-12 | 12 | $160 | $90 | $115.3 | $19.36 | 495.56% |
| 2022-02-07 | 12 | $160 | $90 | $113 | $19.36 | 483.68% |
| 2022-02-24 | 13 | $160 | $65 | $101.6 | $19.36 | 424.79% |
| 2022-03-01 | 13 | $160 | $65 | $98.727 | $19.36 | 409.95% |
| 2022-04-11 | 13 | $160 | $64 | $95.833 | $19.36 | 395.01% |
| 2022-04-13 | 13 | $160 | $64 | $96.5 | $19.36 | 398.45% |
| 2022-05-06 | 13 | $160 | $64 | $91.083 | $19.36 | 370.47% |
| 2022-05-24 | 13 | $160 | $64 | $90.25 | $19.36 | 366.17% |
| 2022-05-26 | 13 | $150 | $64 | $84.833 | $19.36 | 338.19% |
| 2022-06-07 | 11 | $116 | $55 | $76.4 | $19.36 | 294.63% |
| 2022-08-04 | 11 | $97 | $45 | $66.4 | $19.36 | 242.98% |
| 2022-09-17 | 10 | $97 | $45 | $66.4 | $19.36 | 242.98% |
| 2022-10-11 | 11 | $97 | $45 | $65.9 | $19.36 | 240.39% |
| 2022-10-12 | 11 | $97 | $31 | $62.727 | $19.36 | 224% |
| 2022-11-03 | 11 | $97 | $31 | $60.636 | $19.36 | 213.2% |
| 2022-11-18 | 11 | $97 | $31 | $59.818 | $19.36 | 208.98% |
| 2022-12-05 | 11 | $97 | $31 | $60.181 | $19.36 | 210.85% |
| 2022-12-12 | 11 | $97 | $31 | $56.272 | $19.36 | 190.66% |
| 2022-12-20 | 12 | $95 | $31 | $53.181 | $19.36 | 174.7% |
| 2023-01-06 | 12 | $95 | $31 | $52.545 | $19.36 | 171.41% |
| 2023-01-13 | 12 | $95 | $33 | $52.272 | $19.36 | 170% |
| 2023-01-26 | 12 | $95 | $33 | $52.181 | $19.36 | 169.53% |
| 2023-02-17 | 12 | $95 | $33 | $52.727 | $19.36 | 172.35% |
| 2023-02-26 | 12 | $95 | $33 | $50.9 | $19.36 | 162.91% |
| 2023-04-13 | 13 | $95 | $33 | $49.909 | $19.36 | 157.79% |
| 2023-04-17 | 13 | $95 | $33 | $49.727 | $19.36 | 156.85% |
| 2023-04-27 | 13 | $76 | $31 | $47.272 | $19.36 | 144.17% |
| 2023-05-15 | 13 | $76 | $31 | $44.083 | $19.36 | 127.7% |
| 2023-05-18 | 13 | $76 | $31 | $43.916 | $19.36 | 126.84% |
| 2023-06-06 | 14 | $76 | $29 | $42.307 | $19.36 | 118.53% |
| 2023-06-07 | 14 | $75 | $27 | $39.538 | $19.36 | 104.23% |
| 2023-06-28 | 14 | $75 | $27 | $38.615 | $19.36 | 99.46% |
| 2023-07-17 | 15 | $75 | $27 | $37.846 | $19.36 | 95.49% |
| 2023-07-19 | 15 | $75 | $26 | $36.785 | $19.36 | 90.01% |
| 2023-08-01 | 15 | $75 | $22 | $36.142 | $19.36 | 86.68% |
| 2023-08-02 | 15 | $57 | $22 | $29.5 | $19.36 | 52.38% |
| 2023-08-21 | 15 | $57 | $21 | $29.071 | $19.36 | 50.16% |
| 2023-10-13 | 15 | $57 | $18.5 | $28.607 | $19.36 | 47.76% |
| 2023-10-18 | 15 | $57 | $17 | $27.107 | $19.36 | 40.02% |
| 2023-11-03 | 15 | $40 | $13 | $22.285 | $19.36 | 15.11% |
| 2023-12-01 | 15 | $40 | $13 | $21.571 | $19.36 | 11.42% |
| 2023-12-11 | 15 | $40 | $13 | $21.928 | $19.36 | 13.26% |
| 2023-12-21 | 15 | $40 | $13 | $21.785 | $19.36 | 12.53% |
| 2023-12-22 | 15 | $40 | $13 | $22 | $19.36 | 13.64% |
The Trend in the Analyst Price Target
NVRO's average price target has moved down $73.83 over the prior 21 months.
NVRO reports an average of 47.1% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-09 | 12 | 95 | 33 | 52.727 | 36.73 | 43.55% |
| 2023-02-17 | 12 | 95 | 33 | 52.727 | 35.98 | 46.55% |
| 2023-04-27 | 13 | 76 | 31 | 44.454 | 30.32 | 46.62% |
| 2023-05-15 | 13 | 76 | 31 | 44.083 | 28.33 | 55.61% |
| 2023-11-03 | 15 | 57 | 13 | 25.357 | 16.07 | 57.79% |
NVRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.93 | 2 | 1 | 9 | 1 | 1 | 15 |
The Trend in the Broker Recommendations
NVRO's average broker recommendation rating worsened by 1.26 over the prior 46 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, NEVRO CORP's variance in analysts' estimates is lower than -5188.81% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, NEVRO CORP's number of analysts covering the stock is higher than 5273.36% of them.
- In terms of how NEVRO CORP fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 4836.06% of that group.
- NVRO has a higher average analyst price target than 3900.35% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NEVRO CORP are ATEC, ATRC, and GMED.
View All Top Stocks by Price Target
What is the outlook for NVRO? Use POWR Ratings for clearer insight into price direction.